Skip to main content
TipRanks
Go Ultimate75% OFF

Sinopharm Group Co (1099) Income Statement

11 Followers

Sinopharm Group Co Income Statement

Last quarter (Q2 2026), Sinopharm Group Co's total revenue was ¥278.90B, a decrease of 5.37% from the same quarter last year. In Q2, Sinopharm Group Co's net income was ¥3.36B. See Sinopharm Group Co’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 575.17B¥ 584.51B¥ 596.57B¥ 552.15B¥ 521.05B
¥ 41.67B¥ 44.26B¥ 48.51B¥ 47.43B¥ 44.05B
¥ 25.63B¥ 28.07B¥ 28.30B¥ 26.83B¥ 24.34B
Depreciation and Amortization¥ 4.29B¥ 4.74B¥ 4.43B¥ 4.17B¥ 3.92B
¥ 21.52B¥ 22.56B¥ 26.90B¥ 26.25B¥ 24.68B
¥ 16.04B¥ 16.19B¥ 20.21B¥ 20.60B¥ 19.71B
¥ -1.24B¥ -2.19B¥ -697.06M¥ -2.04B¥ -2.71B
¥ 14.80B¥ 14.00B¥ 19.51B¥ 18.56B¥ 17.00B
¥ 7.16B¥ 7.05B¥ 9.05B¥ 8.53B¥ 7.76B
Per Share Metrics
Basic EPS¥ 2.29¥ 2.26¥ 2.90¥ 2.73¥ 2.49
Diluted EPS¥ 2.29¥ 2.26¥ 2.90¥ 2.73¥ 2.49
Weighted Average Shares Outstanding3.12B3.12B3.12B3.12B3.11B
Weighted Average Shares Outstanding (Diluted)3.12B3.12B3.12B3.12B3.11B

Currency in CNY

Sinopharm Group Co Earnings and Revenue History

0250B500B750B0.8 %1.6 %2.4 %3.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin